Effects of feiyanning formula on expressions of mRNAs and proteins of CXCL12 and CXCR4 in mice with Lewis tumors

Journal of Chinese Integrative Medicine

Volumn 7, Issue 2, 2009, Pages 125-129

  Wu, Ji ^a   Bai, Bing ^a   Xu, Zhen Ye ^a   Wang, Zhong Qi ^a   Zhao, Xiao Zhen ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

CXCR4 receptors CXC chemokines; Feiyanning; Lewis lung carcinoma; Mice

Indexed keywords

ANTINEOPLASTIC AGENT; CHEMOKINE RECEPTOR CXCR4; CHINESE DRUG; FEIYANNING; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HERBACEOUS AGENT; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER TISSUE; CHINESE MEDICINE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LEWIS CARCINOMA; LUNG METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CARCINOMA, LEWIS LUNG; CHEMOKINE CXCL12; DRUGS, CHINESE HERBAL; FEMALE; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; RECEPTORS, CXCR4;

EID: 68949086826     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20090206     Document Type: Article

References (10)

1. Shields PG, Harris CC. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol. 2000; 18(11): 2309-2315.
2. Xu ZY, Wang ZQ, Zhu YW, Zhou WD, Zhang H, Deng HB, Zhang M, Gao H, Jiang WJ. Influence of "Feiyanning Decoction" on late non-small cell lung cancer metastasis and serum vascular endothelial growth factor. Shanghai Zhong Yi Yao Da Xue Xue Bao. 2003; 17(3): 18-22.
3. Wang J, Ou ZL, Shao ZM. CXCL12-CXCR4 biological axis and tumor metastasis. Guo Wai Yi Xue Zhong Liu Xue Fen Ce. 2004; 31(5): 326-330.
4. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E, Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001; 410(6824): 50-56.
5. Kato M, Kitayama S, Kazama S, Nagawa H. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res. 2003; 5 (5): R144-R150.
6. Libura J, Drukala J, Majka M, Tomescu O, Navenot JM, Kucia M, Marquez L, Peiper SC, Barr FG, Janowska-Wieczorek A, Ratajczak VIZ. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood. 2002; 100(7): 2597-2606.
7. Gazitt Y. Homing and mobilization of hematopoietic stem cells and hematopoietic cancer cells are mirror image processes, utilizing similar signaling pathways and occurring concurrently: circulating cancer cells constitute an ideal target for concurrent treatment with chemotherapy and antilineage-specific antibodies. Leukemia. 2004; 18(1): 1-10.
8. Su LP, Zhang JP, Zheng XJ, Chu YW, Xiong SD. The effect of the expression level of CXCL4 on the metastatic potential of human lung cancer cells. Zhongguo Zhong Liu Sheng Wu Zhi Liao Za Zhi. 2005; 12(1): 46-51.
9. Jiang YP, Wu XH, Wu WX, Yin GR. Expressions of chemokine CXCL12 and its receptor CXCR4 and the clinical significance in human epithelial ovarian cancer. Zhong Liu. 2006; 26(9): 851-855.
10. Ma XT, Yu LW, Wang S, Du RY, Cui ZR. Relationship between the CXC chemokine receptor-4/CXCL12 signal transduction pathway and lymph node metastasis of gastric carcinoma. Zhongguo Zhong Liu Lin Chuang. 2007; 34(10): 544-546, 549.